Published in Br J Pharmacol on May 01, 1988
Role of intestinal microflora in chronic inflammation and ulceration of the rat colon. Gut (1994) 1.47
NCX-1015, a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc Natl Acad Sci U S A (2002) 1.36
Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut (1990) 1.34
Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut (1999) 1.07
Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br J Pharmacol (2006) 1.06
Colitis and colonic mucosal barrier dysfunction. Gut (1995) 0.96
Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage. Br J Pharmacol (1988) 0.94
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. Br J Pharmacol (2010) 0.93
Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase. Br J Pharmacol (2007) 0.93
Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C. Gut (1992) 0.90
Brain activation in response to visceral stimulation in rats with amygdala implants of corticosterone: an FMRI study. PLoS One (2010) 0.87
Induction of nitric oxide synthase in rat intestine and its association with tissue injury. Agents Actions (1993) 0.83
Evaluation of new therapies for inflammatory bowel disease. Br J Clin Pharmacol (2003) 0.81
A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat. Arthritis Res Ther (2005) 0.81
Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids. Lipids Health Dis (2016) 0.75
Effect of ethanol on eicosanoid synthesis by human gastric and colonic mucosal pieces. Br J Pharmacol (1990) 0.75
A novel model for studying ileitis-induced visceral hypersensitivity in goats. Acta Vet Scand (2016) 0.75
Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science (1983) 9.51
Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature (1979) 4.41
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature (1980) 4.29
Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. Gastroenterology (1978) 4.14
A radioimmunoassay for 6-keto-prostaglandin F1alpha. Prostaglandins (1978) 4.13
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology (1984) 3.99
A new approach to anti-inflammatory drugs. Biochem Pharmacol (1979) 2.95
Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology (1973) 2.72
Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology (1981) 2.13
The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J Pharm Pharmacol (1983) 2.00
A radioimmunoassay for leukotriene B4. Prostaglandins (1982) 1.86
Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology (1981) 1.81
Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease. Gastroenterology (1985) 1.75
Eicosanoids in inflammation. Ann Clin Res (1984) 1.50
The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageenin-induced inflammation. Eur J Pharmacol (1980) 1.48
Determination of prostaglandin synthetase activity in rectal biopsy material and its significance in colonic disease. Gut (1978) 1.47
Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut (1983) 1.37
Studies of prostaglandins and sulphasalazine in ulcerative colitis. Prostaglandins Med (1981) 1.32
In vivo production of leukotriene B4 and leukotriene C4 in rabbit colitis. Relationship to inflammation. Gastroenterology (1987) 1.19
Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci (1985) 1.16
Changes in colonic tissue levels of inflammatory mediators in a guinea-pig model of immune colitis. Agents Actions (1982) 0.87
Increased metabolism of arachidonic acid in an immune model of colitis in guinea-pigs. Br J Pharmacol (1985) 0.86
Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology (1989) 7.59
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med (2000) 3.71
Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J (1989) 3.70
1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem (1997) 3.52
Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology (1989) 3.24
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med (2001) 3.17
Gastric mucosal blood flow during pentagastrin- and histamine-stimulated acid secretion in the rat. Br J Pharmacol (1973) 2.55
Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology (1993) 2.46
Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J Clin Invest (1996) 2.31
A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology (1995) 2.30
Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature (1980) 2.24
Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet (1993) 2.20
Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology (1981) 2.13
Proceedings: Effects of prostaglandin E2 on rat gastric mucosal blood flow, as determined by 14C-aniline clearance. Br J Pharmacol (1972) 2.08
Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci (2001) 2.06
Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol (1990) 1.94
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species. Prostaglandins (1978) 1.85
Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci U S A (2001) 1.84
Characterization of the inflammatory response to proteinase-activated receptor-2 (PAR2)-activating peptides in the rat paw. Br J Pharmacol (1999) 1.83
Suppression of fever at near term is associated with reduced COX-2 protein expression in rat hypothalamus. Am J Physiol Regul Integr Comp Physiol (2002) 1.80
The effects E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat. Br J Pharmacol (1973) 1.79
Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature (1986) 1.73
Radioisotope determination of regional colonic transit in severe constipation: comparison with radio opaque markers. Gut (1993) 1.71
Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology (1997) 1.69
Mechanisms underlying gastric mucosal damage induced by indomethacin and bile-salts, and the actions of prostaglandins. Br J Pharmacol (1977) 1.68
Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature (1981) 1.62
Proteinase-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci U S A (1998) 1.61
Representation of three-dimensional objects by the rat perirhinal cortex. Hippocampus (2012) 1.60
The vasodilator role of endogenous nitric oxide in the rat gastric microcirculation. Eur J Pharmacol (1989) 1.60
The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol (1993) 1.51
Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol (1993) 1.47
Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol (1990) 1.46
Investigation of the vasodilator and antisecretory role of prostaglandins in the rat gastric mucosa by use of non-steroidal anti-inflammatory drugs. Br J Pharmacol (1975) 1.46
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis. Br J Pharmacol (2007) 1.45
Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol (1994) 1.44
Protective effect of S-nitroso-N-acetyl-penicillamine in endotoxin-induced acute intestinal damage in the rat. Eur J Pharmacol (1990) 1.41
Pulmonary infiltration after exposure to home renovation dust: histopathology and microanalysis. Thorax (1996) 1.40
Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci U S A (2001) 1.39
Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro. Prostaglandins (1978) 1.39
Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa. Gut (1983) 1.37
Potency and selectivity of methyl analogues of prostaglandin E2 on rat gastrointestinal function. Br J Pharmacol (1975) 1.36
Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol (1995) 1.36
Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins. Eur J Pharmacol (1976) 1.35
The chemokine RANTES is a crucial mediator of the progression from acute to chronic colitis in the rat. J Immunol (2001) 1.32
Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol (1995) 1.31
Nitric oxide donors increase mucus gel thickness in rat stomach. Eur J Pharmacol (1992) 1.31
Uptake and inactivation of prostaglandin E2 methyl analogues in the rat pulmonary circulation. Br J Pharmacol (1978) 1.30
Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo. Eur J Pharmacol (1988) 1.28
Nitric Oxide. V. therapeutic potential of nitric oxide donors and inhibitors. Am J Physiol (1999) 1.27
Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions (1988) 1.27
NO-naproxen vs. naproxen: ulcerogenic, analgesic and anti-inflammatory effects. Aliment Pharmacol Ther (1997) 1.26
Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol (2000) 1.25
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology (1987) 1.24
Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am J Physiol Gastrointest Liver Physiol (2001) 1.23
Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion. Gastroenterology (1992) 1.22
Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase. Am J Physiol (1999) 1.21
A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet (1994) 1.20
Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol (1997) 1.19
Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci (1989) 1.19
Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanism. Br J Pharmacol (2001) 1.18
Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol (1993) 1.17
Endogenous nitric oxide and sensory neuropeptides interact in the modulation of the rat gastric microcirculation. Br J Pharmacol (1992) 1.17
Gastric vasoconstrictor actions of leukotriene C4, PGF2 alpha, and thromboxane mimetic U-46619 on rat submucosal microcirculation in vivo. Am J Physiol (1985) 1.17
Platelet and cardiovascular activity of the hydantoin BW245C, a potent prostaglandin analogue. Prostaglandins (1983) 1.16
Pharmacological interactions between prostacyclin and thromboxanes. Br Med Bull (1983) 1.16
Beneficial effects of local or systemic lidocaine in experimental colitis. Am J Physiol (1994) 1.16
Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci (1985) 1.16
Role of mucus in the repair of gastric epithelial damage in the rat. Inhibition of epithelial recovery by mucolytic agents. Gastroenterology (1986) 1.16
Proteinase-activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol (2000) 1.15
Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol (1994) 1.15
Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation. Prostaglandins (1980) 1.15
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis. Br J Pharmacol (2000) 1.14
Tumor necrosis factor mediation of NSAID-induced gastric damage: role of leukocyte adherence. Am J Physiol (1996) 1.14
Role of prostanoids in the protective actions of BW755C on the gastric mucosa. Eur J Pharmacol (1985) 1.14
Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol (1992) 1.13
Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat. Br J Pharmacol (1993) 1.13
Effects of indomethacin on rat gastric acid secretion and mucosal blood flow. Br J Pharmacol (1973) 1.13
Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat. Br J Pharmacol (1988) 1.13
Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa. Am J Physiol (1986) 1.13
Prostaglandin E2 and the stimulation of rat gastric acid secretion by dibutyryl cyclic 3',5'-AMP. Eur J Pharmacol (1974) 1.12
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci (1998) 1.11
Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1). Br J Pharmacol (1999) 1.11
Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart. Proc Natl Acad Sci U S A (2000) 1.11
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo. Eur J Pharmacol (1992) 1.11
The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol (1993) 1.10
Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor. Eur J Pharmacol (1986) 1.10
Picomole doses of platelet-activating factor predispose the gastric mucosa to damage by topical irritants. Prostaglandins (1986) 1.10
Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol (2000) 1.09
Ultrastructure of the tegument of adult Schistosoma mansoni. J Parasitol (1968) 1.09
Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol (1991) 1.09
Close-arterial administration of the thromboxane mimetic U-46619 induces damage to the rat gastric mucosa. Prostaglandins (1988) 1.08
Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol (2000) 1.07
Actions of nitric oxide on the release of prostacyclin from bovine endothelial cells in culture. Eur J Pharmacol (1988) 1.07